Incyclix Bio Announces FDA Clearance of Investigational New Drug Application for INX-315 in Patients with Advanced or Metastatic Cancer
28 févr. 2023 07h30 HE
|
Incyclix Bio
– INX-315 is a novel, potent and selective inhibitor of CDK2 with compelling pre-clinical efficacy and safety data– First-in-human, Phase 1/2 study of INX-315 in patients with ER+/HER2- breast...
Data443 To Expand Research Triangle Park Footprint as First Tenant for Horseshoe at Hub RTP Facilities
02 nov. 2022 08h00 HE
|
Data443 Risk Mitigation, Inc.
Offices to be Designed to Attract Additional Talent for Growth Research Triangle Park, NC, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Data443 Risk Mitigation, Inc. (“Data443”) (OTCPK: ATDS), a data...
Data443 Expands Investment in Research Triangle Park with New Location
22 sept. 2022 08h00 HE
|
Data443 Risk Mitigation, Inc.
Research Triangle Park, NC, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Data443 Risk Mitigation, Inc. (“Data443”) (OTCPK: ATDS), a leading data security and privacy software company for ALL THINGS DATA...
Researchers Investigate Nature’s Smallest “Social Cheaters”
14 sept. 2022 12h30 HE
|
Burroughs Wellcome Fund
Research Triangle Park, N.C., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Being a member of a community often requires sacrifice. Species from across the animal kingdom have been shown to cooperate with...
MERRITT TW CROSSING REACHES FULL OCCUPANCY IN DURHAM, NC
18 juil. 2022 15h21 HE
|
Merritt Properties
Durham, NC, July 18, 2022 (GLOBE NEWSWIRE) -- Merritt Properties announced today that it has achieved 100 percent occupancy at Merritt TW Crossing, the commercial real estate developer’s first...
DATA443 TRIPLES DATA CENTER STORAGE CAPACITY DUE TO SIGNIFICANT INCREASE IN CUSTOMER CONSUMPTION
27 nov. 2020 11h12 HE
|
Data443 Risk Mitigation, Inc.
Customer Reliance and Trust in Data443 Capabilities, Including Privacy and Security Capability for Data Storage and Processing, Increasing Exponentially RESEARCH TRIANGLE PARK, NC, Nov. 27, 2020 ...